CRA is a proud sponsor of this event.
Dan McGavock is speaking during the webinar to provide recent developments relating to noteable unfair competeition and trade secret misappropriation claims.
For more information on this event, click here.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...